Genmab revenue increased 21% compared to the first nine months of 2024, to $2,662 million FDA granted BTD to Rina-S ® in advanced endometrial cancer Epcoritamab Phase 3 EPCORE ® FL-1 trial met dual ...

Discover Otter Tail Corp's Q3 2025 earnings call insights—capital growth, updated EPS guidance, and strong utility outlook.

November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab's proposed acquisition of Merus N.V. (Merus)Genmab revenue increased ...

Viridian Therapeutics, Inc. nears profitability and gears up for veligrotug’s 2025 launch. Click here to find out why VRDN stock is a Strong Buy.

John Cena will appear for the final time in Boston on a stacked edition of WWE Raw. What will the 17-time world champion say ...

Otter Tail Corporation (NASDAQ: OTTR) Q3 2025 Earnings Call Transcript November 4, 2025 Operator: Good morning, and welcome ...

The Packers are 1-4 against the Eagles in LaFleur's tenure. It's time to start turning that around. I don't know if this is the right place to mention this, but last week I ordered a giant box of FULL ...

Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA ...

Operator: Good morning, and good evening. Thank you all for joining the conference call for the SK Telecom earnings results.

Like the watch and whisky worlds, there are levels to the audio world. However, I tend to approach things from a consumer, ...

Dr. Weber is currently an Assistant Professor at the Johns Hopkins School of Medicine. He previously served as a Medical Officer and Clinical Reviewer at The US Food and Drug Administration (FDA) and ...

Zai Lab Limited today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates. "Zai Lab is entering the next phase of our growth, powered ...